SEC Form 4 · accession 0001209191-16-122931

LEMAITRE VASCULAR INC · LMAT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Senior V. P., Operations

Period of report

May 20, 2016

Accepted (ET)

May 24, 2016 · 4:37 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001158895

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock^F1	May 20, 2016	S	8,088	$15.0157	D	12,204	D
Common Stock^F2	May 23, 2016	S	8,377	$15.0245	D	3,827	D
Common Stock^F3	May 23, 2016	M	1,500	$4.70	A	5,327	D
Common Stock^F3	May 23, 2016	M	14,280	$5.85	A	19,607	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right to Buy)^F4	$4.70	May 23, 2016	M	1,500	D	Feb 25, 2010	Feb 25, 2017	Common Stock	1,500	0	D
Stock Option (Right to Buy)^F4	$5.85	May 23, 2016	M	14,280	D	Jul 26, 2010	Jul 26, 2017	Common Stock	14,280	0	D

F1The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $15.00 to $15.05. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
F2The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $15.00 to $15.12. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
F3Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.
F4This option is fully vested and exercisable.